Aditya Birla Sun Life Pharma & Healthcare Fund Dir...
(Scheme Rating)
NAV as of Aug 29, 2024
25.42-0.12%
(Earn upto 1.36% Extra Returns with Direct Plan)
Fund Category:
Equity: Sectoral-Pharma
Expense Ratio:
0.94%(0.76% Category
average)Fund Size:
Rs. 791.70 Cr(3.01% of Investment in Category)
- Invest in MFADD TO PORTFOLIO
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-ID...
(Scheme Rating)
NAV as of Aug 29, 2024
25.42-0.12%
Expense Ratio:
0.94%
Fund Size:
Rs. 791.70 Cr
Fund Category:
Equity: Sectoral-Pharma
1. Current NAV: The Current Net Asset Value of the Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan as of Aug 29, 2024 is Rs 25.42 for IDCW option of its Direct plan.
2. Returns: Its trailing returns over different time periods are: 54.42% (1yr), 19.03% (3yr), 27.86% (5yr) and 27.04% (since launch). Whereas, Category returns for the same time duration are: 51.51% (1yr), 18.32% (3yr) and 29.3% (5yr).
3. Fund Size: The Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan currently holds Assets under Management worth of Rs 791.7 crore as on Jul 31, 2024.
4. Expense ratio: The expense ratio of the fund is 0.97% for Direct plan as on Jul 31, 2024.
5. Exit Load: Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan shall attract an Exit Load, "Exit load of 1% if redeemed within 30 days."
6. Minimum Investment: Minimum investment required is Rs 1000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 100.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Returns
Trailing Returns
Rolling Returns
Discrete Period
SIP Returns
1M 3M 6M 1Y 3Y 5Y Annualized Returns 5.66 18.85 19.64 54.48 18.96 27.60 Category Avg 5.77 19.05 20.99 51.30 18.19 28.97 Rank within Category 11 11 13 5 8 8 No. of funds within Category 23 23 22 18 13 9 - Loading...
- Loading...
Return Comparison
- This Fund
- BenchmarkBSE Healthcare Total Return Index
Choose from Benchmarks
- S&P BSE Sensex
- Nifty 50
- 1M
- 3M
- 6M
- 1Y
- 5Y
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Fund Details
Investment Objective - The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Fund House | Aditya Birla Sun Life Mutual Fund |
Launch Date | Jul 10, 2019 |
Benchmark | BSE Healthcare Total Return Index |
Return Since Launch | 26.99% |
Riskometer | Very High |
Type | Open-ended |
Risk Grade | Above Average |
Return Grade | Average |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Investment Details
Minimum Investment (Rs.) | 1,000.00 |
Minimum Additional Investment (Rs.) | 1,000.00 |
Minimum SIP Investment (Rs.) | 100.00 |
Minimum Withdrawal (Rs.) | 1.00 |
Exit Load Exit load of 1% if redeemed within 30 days. |
Portfolio Allocation
Asset Allocation
Asset Allocation History
Sector Allocation
Market Cap Allocation
Concentration & Valuation Analysis
JUL 2024 | JUN 2024 | MAY 2024 | APR 2024 | MAR 2024 | FEB 2024 | |
---|---|---|---|---|---|---|
Number of Holdings | 26 | 25 | 25 | 27 | 27 | 28 |
Top 5 Company Holdings | 43.25% | 43.16% | 43.48% | 41.0% | 42.47% | 41.75% |
Top 10 Company Holdings | 65.33% | 64.54% | 65.54% | 61.16% | 61.91% | 61.99% |
Company with Highest Exposure | Sun Pharmaceutical Industries (14.9%) | Sun Pharmaceutical Industries (14.63%) | Sun Pharmaceutical Industries (14.66%) | Sun Pharmaceutical Industries (14.84%) | Sun Pharmaceutical Industries (15.74%) | Sun Pharmaceutical Industries (15.09%) |
Number of Sectors | 4 | 4 | 4 | 4 | 4 | 4 |
Top 3 Sector Holdings | 96.55% | 95.55% | 96.75% | 94.83% | 92.64% | 93.02% |
Top 5 Sector Holdings | 97.64% | 96.59% | 97.74% | 95.28% | 93.04% | 93.48% |
Sector with Highest Exposure | Healthcare (93.59%) | Healthcare (92.53%) | Healthcare (93.86%) | Healthcare (91.77%) | Healthcare (89.7%) | Healthcare (89.98%) |
Top Stock Holdings
Sector Holdings in MF
Company Sector Assest(%) P/E EPS-TTM(₹) RETURN 1 YR(%) Sun Pharmaceutical Industries Healthcare 14.9 42.18 43.30 61.86 Cipla Healthcare 8.19 30.97 53.29 31.62 Torrent Pharmaceuticals Healthcare 7.8 68.98 51.26 75.34 Apollo Hospitals Enterprise Healthcare 6.18 96.39 72.14 40.56 Aurobindo Pharma Healthcare 6.18 26.10 60.10 88.60 Zydus Lifesciences Healthcare 4.88 26.81 42.92 79.14 Fortis Healthcare Healthcare 4.61 64.50 8.65 61.08 Ajanta Pharma Healthcare 4.4 46.13 68.37 82.71 Gland Pharma Healthcare 4.22 - - - Lupin Healthcare 3.97 45.17 49.64 99.85
![Discover Mutual Funds](/https/economictimes.indiatimes.com/photo/msid-100097201,quality-100/discover-mf.jpg)
Peer Comparison
Cumulative Returns
SIP returns
Discrete Returns
Quant Measures
Asset Allocation
Scheme Name NAV(Rs./Unit) Scheme Rating AUM(Rs. Cr) 1M 1Y 3Y 5Y Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW 25.42 791.70 5.66 54.48 18.96 27.60 SBI Healthcare Opportunities Fund Direct Plan-IDCW 319.32 2,979.52 6.18 47.35 22.18 31.33 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-IDCW 26.33 4,500.25 6.63 60.27 22.63 33.22 Tata India Pharma & Healthcare Fund Direct-IDCW 34.96 1,056.02 6.47 55.01 21.36 30.41 Mirae Asset Healthcare Fund Direct-IDCW 29.86 2,560.38 6.72 52.11 19.75 32.56
Risk Ratios
Ratios are calculated using the calendar month returns for the last 3 years
Standard Deviation
Standard Deviation
Standard deviation is the deviation of the fund's return around mean.
High Volatality
15.93VS15.22Fund Vs Category Avg
Beta
Beta
Beta shows the portfolio risk in relation to the market. A beta of less than 1 means that the fund returns are less volatile compared to the broader market. A beta of more than 1 means that the fund returns are more volatile than the broader markets. A beta equal to 1 means that fund's volatility is in line with the broader market.
High Volatality
0.97VS0.92Fund Vs Category Avg
Sharpe Ratio
Sharpe Ratio
Sharpe ratio is a risk adjusted performance measure. A fund with a higher Sharpe ratio is considered better than a fund with a lower Sharpe ratio.
Poor risk-adjusted returns
0.75VS0.79Fund Vs Category Avg
Treynor's Ratio
Treynor's Ratio
Treynor is a risk adjusted performance measure. A fund with a higher Treynor ratio is considered better than a fund with a lower Treynor ratio.
Poor risk-adjusted returns
12.40VS13.04Fund Vs Category Avg
Jensen's Alpha
Jensen's Alpha
Alpha shows the ability of the fund manager to outperform the market. A higher Alpha is preferred.
Poor risk-adjusted returns
1.30VS1.82Fund Vs Category Avg
Mean Return
Mean Return
Average return generated by the fund during a specified period.
Poor average monthly returns
17.50VS17.51Fund Vs Category Avg
Risk Ratio Chart
- Risk Ratio
- Category Average
Aditya Birla Sun Life Mutual Fund News
Fund Manager
- D.S.Dhaval ShahSince Jun 20196 schemes
Mr.Shah has done B.Com. from University of Mumbai & MBA from Somaiya Institute of Management Studies & Research. He also holds CFA designation. Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y Aditya Birla Sun Life Retirement Fund - The 40s Plan Direct-IDCW Aggressive Hybrid 18.30 113.87 28.03 Aditya Birla Sun Life Retirement Fund - The 50s Plan Direct-IDCW Conservative Hybrid 13.95 27.62 13.89 Aditya Birla Sun Life Retirement Fund - The 50s Plus - Debt Plan Direct-IDCW Corporate Bond 12.52 16.27 7.27 Aditya Birla Sun Life Retirement Fund - The 30s Plan Direct-IDCW Flexi Cap 19.90 403.37 34.64 Aditya Birla Sun Life Multi Asset Allocation Fund Direct-IDCW Multi Asset Allocation 14.27 Unrated 3,508.90 27.60 Aditya Birla Sun Life Multi-Cap Fund Direct-IDCW Multi Cap 20.82 Unrated 6,197.85 40.01
More Aditya Birla Sun Life Mutual Fund
Scheme Name | Rating | Asset Size(Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
Aditya Birla Sun Life Liquid Fund Direct-Growth | 43,962.04 | 0.60 | 1.85 | 3.62 | 7.37 | 5.45 | |
Aditya Birla Sun Life Frontline Equity Direct Fund-Growth | 26,479.89 | 2.87 | 7.63 | 12.95 | 33.96 | 16.55 | |
Aditya Birla Sun Life Corporate Bond Fund Direct-Growth | 21,535.48 | 0.89 | 2.54 | 4.04 | 8.32 | 6.12 | |
Aditya Birla Sun Life Flexi Cap Fund Direct-Growth | 19,767.00 | 1.69 | 8.03 | 13.18 | 37.16 | 16.65 | |
Aditya Birla Sun Life Money Manager Fund Direct-Growth | 19,231.21 | 0.75 | 1.95 | 3.73 | 7.84 | 5.80 | |
Aditya Birla Sun Life ELSS Tax Saver Direct-Growth | 15,006.22 | 1.61 | 7.14 | 11.32 | 32.00 | 9.17 | |
Aditya Birla Sun Life Savings Direct-Growth | 12,705.36 | 0.65 | 1.88 | 3.61 | 7.61 | 5.78 | |
Aditya Birla Sun Life Low Duration Fund Direct-Growth | 12,058.48 | 0.73 | 1.97 | 3.67 | 7.89 | 6.06 | |
Aditya Birla Sun Life Floating Rate Direct Fund-Growth | 11,705.15 | 0.77 | 1.98 | 3.68 | 8.00 | 6.09 | |
Aditya Birla Sun Life Arbitrage Fund Direct-Growth | 10,668.41 | 0.67 | 2.27 | 4.04 | 8.27 | 6.12 |
Mutual Fund Tools
Top AMCs
- SBI Mutual Fund
- ICICI Prudential Mutual Fund
- HDFC Mutual Fund
- Nippon India Mutual Fund
- Kotak Mahindra Mutual Fund
- Aditya Birla Sun Life Mutual Fund
- UTI Mutual Fund
- Axis Mutual Fund
- Mirae Asset Mutual Fund
- Edelweiss Mutual Fund
- DSP Mutual Fund
- Tata Mutual Fund
- Bandhan Mutual Fund
- HSBC Mutual Fund
- Franklin Templeton Mutual Fund
1. Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan is Open-ended Sectoral-Pharma Equity scheme which belongs to Aditya Birla Sun Life Mutual Fund House.
2. The fund was launched on Jul 10, 2019.
Investment objective & Benchmark
1. The investment objective of the fund is that " The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. "
2. It is benchmarked against BSE Healthcare Total Return Index.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 97.63% in equities, 0.0% in debts and 2.37% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 65.33% of the assets, the top 3 sectors constitute around 96.55% of the assets.
3. The fund largely follows a Blend oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
This Might Catch Your Interest
FAQs about Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW
- Is it safe to invest in Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan?As per SEBI’s latest guidelines to calculate risk grades, investment in the Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan comes under Very High risk category.
- What is the category of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan?Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan belongs to the Equity : Sectoral-Pharma category of funds.
- How Long should I Invest in Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan?The suggested investment horizon of investing into Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan is >3 years. The suggested investment horizon is the minimum time required for holding investments in the fund to reduce its downside risk and ensure that the returns become more predictable.
- Who manages the Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan?The Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan is managed by Dhaval Shah (Since Jun 20, 2019).
Date Sources: Mutual Funds, ETFs, and NPS data are sourced from Value Research. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.